Prevention & lipidsCase-control study

Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk

CirculationPublished

  • Nested case-control study
  • nested within the PREDIMED randomised trial cohort
  • individually matched 1:2

Authors' conclusion

Low cholesterol efflux capacity values, pro-oxidant/proinflammatory HDL particles, and low HDL levels of sphingosine-1-phosphate and apolipoprotein A-I were associated with increased odds of acute coronary syndrome and its manifestations in individuals at high cardiovascular risk.

Study context

Population
Individuals at high CV risk in the PREDIMED cohort (Mediterranean or low-fat diet)matched 1:2
Comparison
High-density lipoprotein (HDL) functional characteristics in ACS cases vs matched controls
  • Casesn = 167
Outcome
Incident ACS

Main finding

As reported in the abstract

ACS, OR per 1-SD increment (adjusted for HDL-C and CV risk factors)
Cholesterol efflux capacity
OR1SD 0.58 (95% CI 0.40–0.83)
Sphingosine-1-phosphate
OR1SD 0.70 (95% CI 0.52–0.92)
Apolipoprotein A-I
OR1SD 0.58 (95% CI 0.42–0.79)
HDL oxidative-inflammatory index · marginally linked
OR1SD 1.27 (95% CI 0.99–1.63)

Observational data: associations, not effects.

Secondary outcomes

OutcomeOR1SD (95% CI)
MI, OR per 1-SD increment — Cholesterol efflux capacity0.33 (0.18–0.61)
MI, OR per 1-SD increment — Sphingosine-1-phosphate0.60 (0.40–0.89)
MI, OR per 1-SD increment — Apolipoprotein A-I0.59 (0.37–0.93)
Unstable angina, OR per 1-SD increment — HDL oxidative-inflammatory index1.53 (1.01–2.33)
Unstable angina, OR per 1-SD increment — Apolipoprotein A-I0.52 (0.31–0.88)

Original publication

Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk. Circulation. Published 16 January 2020. doi:10.1161/circulationaha.119.041658

Summarised from the published abstract; every number is checked against it